Evidence map›Paper›PMID 32938966›Full record

ArticleScientific reports2020

Copaifera spp. oleoresins impair Toxoplasma gondii infection in both human trophoblastic cells and human placental explants.

Samuel Cota Teixeira, Guilherme de Souza, Bruna Cristina Borges, Thádia Evelyn de Araújo, Alessandra Monteiro Rosini, Fábio Alves Aguila, Sergio Ricardo Ambrósio, Rodrigo Cassio Sola Veneziani, Jairo Kenupp Bastos, Marcelo José Barbosa Silva and 3 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. The Search for Drugs Derived from Natural Products forCurrent topics in medicinal chemistry · 2024
    Pooled it
  2. Quercetin ReducesInternational journal of molecular sciences · 2026
    Article
  3. Veterinary sciences · 2026
    Review
  4. BthTX-II, an Asp49 PLAPharmaceuticals (Basel, Switzerland) · 2025
    Article
  5. Pathogens (Basel, Switzerland) · 2025
    Article
  6. Article
  7. Article
  8. Novel drug candidates targetingFrontiers in pharmacology · 2025
    Article
  9. Galectin-3 plays a key role in controlling infection byFrontiers in cellular and infection microbiology · 2024
    Article
  10. Nanoformulation-Based 1,2,3-Triazole Sulfonamides for Anti-Tropical medicine and infectious disease · 2023
    Article
  11. Article
  12. Frontiers in immunology · 2023
    Article
  13. Leaf hydroalcoholic extract and oleoresin fromFrontiers in cellular and infection microbiology · 2023
    Article
  14. Article
  15. Antimicrobial, Antivirulence, and Antiparasitic Potential ofAntibiotics (Basel, Switzerland) · 2022
    Article
  16. Pathogens (Basel, Switzerland) · 2022
    Review
  17. Therapeutic Potential and Safety of theFrontiers in cellular and infection microbiology · 2022
    Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Samuel Cota TeixeiraLaboratory of Immunophysiology of Reproduction, Institute of Biomedical Science, Federal University of Uberlândia, Campus Umuarama, Av. Para, 1720, Uberlândia, MG, 38400239, Brazil.
Guilherme de SouzaLaboratory of Immunophysiology of Reproduction, Institute of Biomedical Science, Federal University of Uberlândia, Campus Umuarama, Av. Para, 1720, Uberlândia, MG, 38400239, Brazil.
Bruna Cristina BorgesDepartment of Immunology, Biomedical Sciences Institute, Federal University of Uberlândia, Uberlândia, Brazil.
Thádia Evelyn de AraújoLaboratory of Immunophysiology of Reproduction, Institute of Biomedical Science, Federal University of Uberlândia, Campus Umuarama, Av. Para, 1720, Uberlândia, MG, 38400239, Brazil.
Alessandra Monteiro RosiniLaboratory of Immunophysiology of Reproduction, Institute of Biomedical Science, Federal University of Uberlândia, Campus Umuarama, Av. Para, 1720, Uberlândia, MG, 38400239, Brazil.
Fábio Alves AguilaNucleus of Research in Technological and Exact Sciences, University of Franca, Franca, Brazil.
Sergio Ricardo AmbrósioNucleus of Research in Technological and Exact Sciences, University of Franca, Franca, Brazil.
Rodrigo Cassio Sola VenezianiNucleus of Research in Technological and Exact Sciences, University of Franca, Franca, Brazil.
Jairo Kenupp BastosSchool of Pharmaceutical Sciences of Ribeirao Preto, University of São Paulo, Ribeirão Preto, Brazil.
Marcelo José Barbosa SilvaDepartment of Immunology, Biomedical Sciences Institute, Federal University of Uberlândia, Uberlândia, Brazil.
Carlos Henrique Gomes MartinsDepartment of Microbiology, Biomedical Sciences Institute, Federal University of Uberlândia, Uberlândia, Brazil.
Bellisa de Freitas BarbosaLaboratory of Immunophysiology of Reproduction, Institute of Biomedical Science, Federal University of Uberlândia, Campus Umuarama, Av. Para, 1720, Uberlândia, MG, 38400239, Brazil.
Eloisa Amália Vieira FerroLaboratory of Immunophysiology of Reproduction, Institute of Biomedical Science, Federal University of Uberlândia, Campus Umuarama, Av. Para, 1720, Uberlândia, MG, 38400239, Brazil. eloisa.ferro@ufu.br.
Universidade Federal de Uberlândia · BRUniversidade de Franca · BRUniversidade de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The combination of pyrimethamine and sulfadiazine is the standard care in cases of congenital toxoplasmosis. However, therapy with these drugs is associated with severe and sometimes life-threatening side effects. The investigation of phytotherapeutic alternatives to treat parasitic diseases without acute toxicity is essential for the advancement of current therapeutic practices. The present study investigates the antiparasitic effects of oleoresins from different species of Copaifera genus against T. gondii. Oleoresins from C. reticulata, C. duckei, C. paupera, and C. pubiflora were used to treat human trophoblastic cells (BeWo cells) and human villous explants infected with T. gondii. Our results demonstrated that oleoresins were able to reduce T. gondii intracellular proliferation, adhesion, and invasion. We observed an irreversible concentration-dependent antiparasitic action in infected BeWo cells, as well as parasite cell cycle arrest in the S/M phase. The oleoresins altered the host cell environment by modulation of ROS, IL-6, and MIF production in BeWo cells. Also, Copaifera oleoresins reduced parasite replication and TNF-α release in villous explants. Anti-T. gondii effects triggered by the oleoresins are associated with immunomodulation of the host cells, as well as, direct action on parasites.

Indexed as

AnimalsAntiprotozoal AgentsCell Cycle CheckpointsCell LineCytokinesDose-Response Relationship, DrugFabaceaeFemaleHost-Parasite InteractionsHumansMicroscopy, Electron, TransmissionPhytotherapyPlacentaPlant ExtractsPregnancyPregnancy Complications, ParasiticAntiprotozoal AgentsCytokinesoleoresinsPlant ExtractsReactive Oxygen Species

Identifiers

PMID32938966
PMCPMC7495442
OpenAlexW3087510529

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.